TY - JOUR AU - Yin, J. AU - Xing, H. AU - Ye, J. PY - 2008 DA - 2008// TI - Efficacy of berberine in patients with type 2 diabetes mellitus JO - Metabolism VL - 57 UR - https://doi.org/10.1016/j.metabol.2008.01.013 DO - 10.1016/j.metabol.2008.01.013 ID - Yin2008 ER - TY - JOUR AU - Kong, W. AU - Wei, J. AU - Abidi, P. AU - Lin, M. AU - Inaba, S. AU - Li, C. PY - 2004 DA - 2004// TI - Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins JO - Nat Med VL - 10 UR - https://doi.org/10.1038/nm1135 DO - 10.1038/nm1135 ID - Kong2004 ER - TY - JOUR AU - Lu, S. S. AU - Yu, Y. L. AU - Zhu, H. J. AU - Liu, X. D. AU - Liu, L. AU - Liu, Y. W. PY - 2009 DA - 2009// TI - Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats JO - J Endocrinol VL - 200 UR - https://doi.org/10.1677/JOE-08-0419 DO - 10.1677/JOE-08-0419 ID - Lu2009 ER - TY - JOUR AU - Li, H. AU - Dong, B. AU - Park, S. W. AU - Lee, H. S. AU - Chen, W. AU - Liu, J. PY - 2009 DA - 2009// TI - Hepatocyte nuclear factor 1—plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine JO - J Biol Chem VL - 284 UR - https://doi.org/10.1074/jbc.M109.052407 DO - 10.1074/jbc.M109.052407 ID - Li2009 ER - TY - JOUR AU - Cameron, J. AU - Ranheim, T. AU - Kulseth, M. A. AU - Leren, T. P. AU - Berge, K. E. PY - 2008 DA - 2008// TI - Berberine decreases PCSK9 expression in HepG2cells JO - Atherosclerosis. VL - 201 UR - https://doi.org/10.1016/j.atherosclerosis.2008.02.004 DO - 10.1016/j.atherosclerosis.2008.02.004 ID - Cameron2008 ER - TY - JOUR AU - Dubuc, G. AU - Chamberland, A. AU - Wassef, H. AU - Davignon, J. AU - Seidah, N. G. AU - Bernier, L. AU - Prat, A. PY - 2004 DA - 2004// TI - Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia JO - Arterioscler Thromb Vasc Biol VL - 24 UR - https://doi.org/10.1161/01.ATV.0000134621.14315.43 DO - 10.1161/01.ATV.0000134621.14315.43 ID - Dubuc2004 ER - TY - JOUR AU - Zhang, Y. AU - Li, X. AU - Zou, D. AU - Liu, W. AU - Yang, J. AU - Zhu, N. PY - 2008 DA - 2008// TI - Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine JO - J Clin Endocrinol Metab VL - 93 UR - https://doi.org/10.1210/jc.2007-2404 DO - 10.1210/jc.2007-2404 ID - Zhang2008 ER - TY - JOUR AU - Perry, R. J. AU - Samuel, V. T. AU - Petersen, K. F. AU - Shulman, G. I. PY - 2014 DA - 2014// TI - The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes JO - Nature VL - 510 UR - https://doi.org/10.1038/nature13478 DO - 10.1038/nature13478 ID - Perry2014 ER - TY - JOUR AU - Yan, H. M. AU - Xia, M. F. AU - Wang, Y. AU - Chang, X. X. AU - Yao, X. Z. AU - Rao, S. X. PY - 2015 DA - 2015// TI - Efficacy of berberine in patients with nonalcoholic fatty liver disease JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0134172 DO - 10.1371/journal.pone.0134172 ID - Yan2015 ER - TY - JOUR AU - Puri, P. AU - Baillie, R. A. AU - Wiest, M. M. AU - Mirshahi, F. AU - Choudhury, J. AU - Cheung, O. AU - Sargeant, C. PY - 2007 DA - 2007// TI - A lipidomic analysis of nonalcoholic fatty liver disease JO - Hepatology VL - 46 UR - https://doi.org/10.1002/hep.21763 DO - 10.1002/hep.21763 ID - Puri2007 ER - TY - JOUR AU - Puri, P. AU - Wiest, M. M. AU - Cheung, O. AU - Mirshahi, F. AU - Sargeant, C. AU - Min, H. K. PY - 2009 DA - 2009// TI - The plasma lipidomic signature of nonalcoholic steatohepatitis JO - Hepatology VL - 50 UR - https://doi.org/10.1002/hep.23229 DO - 10.1002/hep.23229 ID - Puri2009 ER - TY - JOUR AU - Cho, E. PY - 1990 DA - 1990// TI - Berberine hydrochloridein JO - Pharmacop People’s Repub China VL - 2 ID - Cho1990 ER - TY - JOUR AU - Astrup, A. AU - Carraro, R. AU - Finer, N. AU - Harper, A. AU - Kunesova, M. AU - Lean, M. E. PY - 2012 DA - 2012// TI - Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide JO - Int J Obes (Lond) VL - 36 UR - https://doi.org/10.1038/ijo.2011.158 DO - 10.1038/ijo.2011.158 ID - Astrup2012 ER - TY - JOUR AU - Tie, C. a. i. AU - Ting, H. u. AU - Zhang, X. i. n. x. i. a. n. g. AU - Zhou, J. i. a. n. g. AU - Zhang, J. i. n. l. a. n. PY - 2014 DA - 2014// TI - HPLC-MRM relative quantification analysis of fatty acids based on anovel derivatization strategy JO - Analyst VL - 139 UR - https://doi.org/10.1039/C4AN01314J DO - 10.1039/C4AN01314J ID - Tie2014 ER - TY - JOUR AU - Feng, Q. u. AU - Zheng, S. u. -. J. u. n. AU - Cai-Sheng, W. u. AU - Jia, Z. h. i. -. X. i. n. AU - Zhang, J. i. n. -. L. a. n. AU - Duan, Z. h. o. n. g. -. P. i. n. g. PY - 2014 DA - 2014// TI - Lipidomic profiling of plasma in patients with chronic hepatitis C infection JO - Anal Bioanal Chem VL - 406 UR - https://doi.org/10.1007/s00216-013-7479-8 DO - 10.1007/s00216-013-7479-8 ID - Feng2014 ER - TY - JOUR AU - Feng, Q. u. AU - Cai-Sheng, W. u. AU - Hou, J. i. n. -. F. e. n. g. AU - Jin, Y. i. n. g. AU - Zhang, J. i. n. -. L. a. n. PY - 2012 DA - 2012// TI - Sphingolipids as new biomarkers for assessment of delayed-type hypersensitivity and response to triptolide JO - PLoS ONE VL - 7 ID - Feng2012 ER - TY - JOUR AU - Chavez, J. A. AU - Siddique, M. M. AU - Wang, S. T. AU - Ching, J. AU - Shayman, J. A. AU - Summers, S. A. PY - 2014 DA - 2014// TI - Ceramides and glucosylceramides are independent antagonists of insulin signaling JO - J Biol Chem VL - 289 UR - https://doi.org/10.1074/jbc.M113.522847 DO - 10.1074/jbc.M113.522847 ID - Chavez2014 ER - TY - JOUR AU - Bikman, B. T. PY - 2012 DA - 2012// TI - A role for sphingolipids in the pathophysiology of obesity-induced inflammation JO - Cell Mol Life Sci VL - 69 UR - https://doi.org/10.1007/s00018-012-0917-5 DO - 10.1007/s00018-012-0917-5 ID - Bikman2012 ER - TY - JOUR AU - Maceyka, M. AU - Spiegel, S. PY - 2014 DA - 2014// TI - Sphingolipid metabolites in inflammatory disease JO - Nature VL - 510 UR - https://doi.org/10.1038/nature13475 DO - 10.1038/nature13475 ID - Maceyka2014 ER - TY - JOUR AU - Pagadala, M. AU - Kasumov, T. AU - McCullough, A. J. AU - Zein, N. N. AU - Kirwan, J. P. PY - 2012 DA - 2012// TI - Role of ceramides in nonalcoholic fatty liver disease JO - Trends Endocrinol Metab VL - 23 UR - https://doi.org/10.1016/j.tem.2012.04.005 DO - 10.1016/j.tem.2012.04.005 ID - Pagadala2012 ER - TY - JOUR AU - Xia, J. Y. AU - Holland, W. L. AU - Kusminski, C. M. AU - Sun, K. AU - Sharma, A. X. AU - Pearson, M. J. PY - 2015 DA - 2015// TI - Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis JO - Cell Metab VL - 22 UR - https://doi.org/10.1016/j.cmet.2015.06.007 DO - 10.1016/j.cmet.2015.06.007 ID - Xia2015 ER - TY - JOUR AU - Summers, S. A. PY - 2010 DA - 2010// TI - Sphingolipids and insulin resistance: the five Ws JO - Curr Opin Lipidol VL - 21 UR - https://doi.org/10.1097/MOL.0b013e3283373b66 DO - 10.1097/MOL.0b013e3283373b66 ID - Summers2010 ER - TY - JOUR AU - Holland, W. L. AU - Summers, S. A. PY - 2008 DA - 2008// TI - Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism JO - Endocr Rev VL - 29 UR - https://doi.org/10.1210/er.2007-0025 DO - 10.1210/er.2007-0025 ID - Holland2008 ER - TY - JOUR AU - Holland, W. L. AU - Knotts, T. A. AU - Chavez, J. A. AU - Wang, L. AU - Hoehn, K. L. AU - Summers, S. A. PY - 2007 DA - 2007// TI - Lipid mediators of insulin resistance JO - Nutr Rev VL - 65(6, part 2) UR - https://doi.org/10.1301/nr.2007.jun.S39-S46 DO - 10.1301/nr.2007.jun.S39-S46 ID - Holland2007 ER - TY - JOUR AU - Stratford, S. AU - DeWald, D. B. AU - Summers, S. A. PY - 2001 DA - 2001// TI - Ceramide dissociates 3′-phosphoinositide production from pleckstrin homology domain translocation JO - Biochem J VL - 354(part 2) UR - https://doi.org/10.1042/bj3540359 DO - 10.1042/bj3540359 ID - Stratford2001 ER - TY - JOUR AU - Salinas, M. AU - López-Valdaliso, R. AU - Martín, D. AU - Alvarez, A. AU - Cuadrado, A. PY - 2000 DA - 2000// TI - Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells JO - Mol Cell Neurosci VL - 15 UR - https://doi.org/10.1006/mcne.1999.0813 DO - 10.1006/mcne.1999.0813 ID - Salinas2000 ER - TY - JOUR AU - Kurek, K. AU - Piotrowska, D. M. AU - Wiesiołek-Kurek, P. AU - Łukaszuk, B. AU - Chabowski, A. AU - Górski, J. AU - Zendzian-Piotrowska, M. PY - 2014 DA - 2014// TI - Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease JO - Liver Int VL - 34 UR - https://doi.org/10.1111/liv.12331 DO - 10.1111/liv.12331 ID - Kurek2014 ER - TY - JOUR AU - Kasumov, T. AU - Li, L. AU - Li, M. AU - Gulshan, K. AU - Kirwan, J. P. AU - Liu, X. PY - 2015 DA - 2015// TI - Ceramide as a mediator of non-alcoholic fatty liver disease and associated atherosclerosis JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0126910 DO - 10.1371/journal.pone.0126910 ID - Kasumov2015 ER - TY - JOUR AU - Summers, S. A. AU - Nelson, D. H. PY - 2005 DA - 2005// TI - A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing’s syndrome JO - Diabetes VL - 54 UR - https://doi.org/10.2337/diabetes.54.3.591 DO - 10.2337/diabetes.54.3.591 ID - Summers2005 ER - TY - JOUR AU - Mitsutake, S. AU - Zama, K. AU - Yokota, H. AU - Yoshida, T. AU - Tanaka, M. AU - Mitsui, M. PY - 2011 DA - 2011// TI - Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes JO - J Biolchem VL - 286 ID - Mitsutake2011 ER - TY - JOUR AU - Shirouchi, B. AU - Nagao, K. AU - Inoue, N. AU - Ohkubo, T. AU - Hibino, H. AU - Yanagita, T. PY - 2007 DA - 2007// TI - Effect of dietary omega 3 phosphatidylcholine on obesity-related disorders in obese Otsuka long-evans Tokushima fatty rats JO - J Agric Food Chem VL - 55 UR - https://doi.org/10.1021/jf071225x DO - 10.1021/jf071225x ID - Shirouchi2007 ER - TY - JOUR AU - Buang, Y. AU - Wang, Y. M. AU - Cha, J. Y. AU - Nagao, K. AU - Yanagita, T. PY - 2005 DA - 2005// TI - . Dietaryphosphatidylcholine alleviates fatty liver induced by oroticacid JO - Nutrition VL - 21 UR - https://doi.org/10.1016/j.nut.2004.11.019 DO - 10.1016/j.nut.2004.11.019 ID - Buang2005 ER - TY - JOUR AU - Wang, M. AU - Wang, F. AU - Wang, Y. AU - Ma, X. AU - Zhao, M. AU - Zhao, C. PY - 2013 DA - 2013// TI - Metabonomics study of the therapeutic mechanism of gynostemmapentaphyllum and atorvastatin for hyperlipidemia in rats JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0078731 DO - 10.1371/journal.pone.0078731 ID - Wang2013 ER - TY - JOUR AU - Jacobs, R. L. AU - Veen, J. N. AU - Vance, D. E. PY - 2013 DA - 2013// TI - Finding the balance: the role of S-adenosylmethionine and phosphatidylcholine metabolism in development of nonalcoholic fatty liver disease JO - Hepatology VL - 58 UR - https://doi.org/10.1002/hep.26499 DO - 10.1002/hep.26499 ID - Jacobs2013 ER - TY - JOUR AU - Sato, A. AU - Kumagai, T. AU - Ebina, K. PY - 2014 DA - 2014// TI - A synthetic biotinylated peptide, BP21, inhibits the induction of mRNA expression of inflammatory substances by oxidized- and lyso-phosphatidylcholine JO - Drug Dev Res VL - 75 UR - https://doi.org/10.1002/ddr.21178 DO - 10.1002/ddr.21178 ID - Sato2014 ER -